CNSL — Cambridge Nutritional Sciences Income Statement
0.000.00%
Last trade - 00:00- £6.31m
- £1.79m
- £8.33m
- 13
- 98
- 37
- 45
Annual income statement for Cambridge Nutritional Sciences, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
R2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 6.82 | 8.54 | 7.55 | 9.77 | 8.33 |
| Cost of Revenue | |||||
| Gross Profit | 4 | 5.1 | 3.54 | 6.05 | 5.44 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 7.28 | 9.47 | 10.8 | 10.5 | 6.89 |
| Operating Profit | -0.468 | -0.929 | -3.24 | -0.773 | 1.44 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -0.546 | -0.95 | -3.25 | -0.745 | 1.57 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 0.385 | -1.41 | -3.17 | -0.328 | 1.57 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -2.1 | -11.3 | -3.86 | -0.328 | 1.57 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.1 | -11.3 | -3.86 | -0.328 | 1.57 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.002 | 0 | -0.012 | -0 | -0.001 |